Correlation between plasma milrinone concentration and renal function in patients with cardiac disease

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 7, 2008, Pages 991-996

  Hasei, M ^a   Uchiyama, A ^a   Nishimura, M ^b   Mashimo, T ^a,c   Fujino, Y ^a  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Creatinine clearance; Milrinone pharmacodynamics plasma concentration of milrinone; Renal failure

Indexed keywords

CREATININE; MILRINONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FEMALE; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CREATININE; FEMALE; HEART DISEASES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MILRINONE; TIME FACTORS;

EID: 46749154224     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01671.x     Document Type: Article

References (13)

1. Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure: mechanisms of action and recent clinical developments. N Engl J Med 1986 314 : 349 58.
2. Anderson JL, Baim DS, Fein SA et al. Efficacy and safety of sustained (48 h) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol 1987 9 : 711 22.
3. Hoffman TM, Wernovsky G, Atz AM et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003 107 : 996 1002.
4. Stroshane RM, Koss RF, Biddlecome CE et al. Oral and intravenous pharmacokinetics of milrinone in human volunteers. J Pharm Sci 1984 73 : 1438 41.
5. Larsson R, Liedholm H, Andersson KE et al. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment. Eur J Clin Pharmacol 1986 29 : 549 53.
6. Holmes JR, Kubo SH, Cody RJ et al. Milrinone in congestive heart failure: observations on ambulatory ventricular arrtythmias. Am Heart J 1986 110 : 800 6.
7. Oddie CJ, Jackman GP, Bobik A. Analysis of milrinone in plasma using solid-phase extraction and high-performance liquid chromatography. J Chromatogr 1986 374 : 209 14.
8. Chang AC, Atz AM, Wernovsky G et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995 23 : 1907 14.
9. Seino Y, Momomura S, Takano T et al. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Crit Care Med 1996 24 : 1490 7.
10. Young RA, Ward A. Milrinone. A preliminary review of its pharmacological properties and therapeutic use. Drugs 1988 36 : 158 92.
11. Bailey JM, Levy JH, Kikura M et al. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 1994 81 : 616 22.
12. Kikura M, Levy JH, Michelsen LG et al. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg 1997 85 : 16 22.
13. Lindsay CA, Barton P, Lawless S et al. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. J Pediatr 1998 132 : 329 34.